Business · 08/03/2000

FDA Releases Draft Guidance on Review Criteria for Antimicrobial Susceptibility Devices

The Food and Drug Administration (FDA) has made available a draft guidance document outlining review criteria for assessing the effectiveness of antimicrobial susceptibility devices, which could pave the way for the reclassification of these devices from class III to class II.